In the case of cancer migration, this is prominently marked by a circumferential invasion array comprised of a high density of actin and myosin II surrounding the tumor invasion pore, with active myosin contraction potentiated at least in part by localized MLCK activity [8]. The gene discussed is MYLK; the disease is cancer.